Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1W93

Crystal Structure of Biotin Carboxylase Domain of Acetyl-Coenzyme A Carboxylase from Saccharomyces cerevisiae

Summary for 1W93
Entry DOI10.2210/pdb1w93/pdb
Related1OD2 1OD4 1UYR 1UYS 1UYT 1UYV 1W2X
DescriptorACETYL-COENZYME A CARBOXYLASE (2 entities in total)
Functional Keywordsobesity, diabetes, fatty acid metabolism, structure-based drug design, allosteric inhibition, polyketide, ligase
Biological sourceSACCHAROMYCES CEREVISIAE (BAKER'S YEAST)
Cellular locationCytoplasm: Q00955
Total number of polymer chains1
Total formula weight61523.17
Authors
Shen, Y.,Volrath, S.L.,Weatherly, S.C.,Elich, T.D.,Tong, L. (deposition date: 2004-10-05, release date: 2005-01-04, Last modification date: 2024-05-08)
Primary citationShen, Y.,Volrath, S.L.,Weatherly, S.C.,Elich, T.D.,Tong, L.
A Mechanism for the Potent Inhibition of Eukaryotic Acetyl-Coenzyme a Carboxylase by Soraphen A, a Macrocyclic Polyketide Natural Product
Mol.Cell, 16:881-, 2004
Cited by
PubMed Abstract: Acetyl-coenzyme A carboxylases (ACCs) have crucial roles in fatty acid metabolism. Soraphen A, a macrocyclic polyketide natural product, is a nanomolar inhibitor against the biotin carboxylase (BC) domain of human, yeast, and other eukaryotic ACCs. Here we report the crystal structures of the yeast BC domain, alone and in complex with soraphen A. Soraphen has extensive interactions with an allosteric site, about 25 A from the active site. The specificity of soraphen is explained by large structural differences between the eukaryotic and prokaryotic BC in its binding site, confirmed by our studies on the effects of single-site mutations in this binding site. Unexpectedly, our structures suggest that soraphen may bind in the BC dimer interface and inhibit the BC activity by disrupting the oligomerization of this domain. Observations from native gel electrophoresis confirm this structural insight. The structural information provides a foundation for structure-based design of new inhibitors against these enzymes.
PubMed: 15610732
DOI: 10.1016/J.MOLCEL.2004.11.034
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon